Phreesia, Inc. $PHR Stock Position Lowered by Blair William & Co. IL

Blair William & Co. IL lessened its position in Phreesia, Inc. (NYSE:PHR) by 2.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 121,308 shares of the company’s stock after selling 3,098 shares during the quarter. Blair William & Co. IL owned approximately 0.20% of Phreesia worth $3,452,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Diversified Trust Co lifted its position in shares of Phreesia by 1.0% in the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company’s stock valued at $1,282,000 after acquiring an additional 426 shares in the last quarter. Arcadia Investment Management Corp MI lifted its position in shares of Phreesia by 0.7% in the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company’s stock worth $2,371,000 after purchasing an additional 615 shares in the last quarter. QRG Capital Management Inc. lifted its position in shares of Phreesia by 8.0% in the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company’s stock worth $284,000 after purchasing an additional 827 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Phreesia by 9.0% in the first quarter. Hsbc Holdings PLC now owns 14,241 shares of the company’s stock worth $356,000 after purchasing an additional 1,177 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its position in shares of Phreesia by 53.0% in the first quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after purchasing an additional 1,825 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on PHR shares. DA Davidson raised shares of Phreesia to a “strong-buy” rating in a research report on Monday, September 8th. Piper Sandler increased their price target on shares of Phreesia from $33.00 to $34.00 and gave the stock an “overweight” rating in a research report on Friday, September 5th. KeyCorp reduced their price target on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Truist Financial increased their price target on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. Finally, JMP Securities raised their price objective on shares of Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a research report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $33.85.

Phreesia Trading Down 0.2%

Shares of PHR stock opened at $22.21 on Tuesday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $32.76. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. The business’s 50 day moving average is $26.45 and its two-hundred day moving average is $26.08. The company has a market cap of $1.33 billion, a PE ratio of -52.89 and a beta of 0.68.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.08. The company had revenue of $117.26 million for the quarter, compared to the consensus estimate of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The company’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter last year, the company posted ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. Equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Balaji Gandhi sold 4,183 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $97,380.24. Following the sale, the chief financial officer owned 99,125 shares in the company, valued at approximately $2,307,630. This trade represents a 4.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider David Linetsky sold 1,064 shares of the firm’s stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $23.50, for a total transaction of $25,004.00. Following the completion of the sale, the insider owned 173,888 shares in the company, valued at approximately $4,086,368. The trade was a 0.61% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 93,469 shares of company stock valued at $2,744,837 in the last 90 days. 5.50% of the stock is currently owned by corporate insiders.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.